Back

Effects of LCZ696 on lipid metabolism in an animal model of heart failure with preserved ejection fraction (HFpEF). Possible implications for the management of obesity associated with HFpEF.

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: Basic science - cardiac disease 1 Heart Failure HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Mr Oscar Otero Garcia

University Hospital of Santiago de Compostela, Santiago de Compostela (Spain)

7 More presentations in this session

Presentation thumbnail
Predicting adverse cardiac remodeling after ST-elevation myocardial infarction with novel biomarkers soluble isoform of suppression tumorigenicity-2 and macrophage migration inhibitory factor
Associate Professor I. Vyshnevska (Kharkiv, UA)
Abstract Slides Video
Presentation thumbnail
Selective beta-3 stimulation with mirabegron improves myocardial function and perfusion in a swine model of hibernated myocardium
Mr D. Perez Camargo (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Role of endothelial p22phox and SGLT2 interplay in pulmonary endothelial and vasculature dysfunction in isoproterenol-induced heart failure in mice
Ms S. Kerth (Munich, DE)
Abstract Slides Video
Presentation thumbnail
Influence of oestrogen on Takotsubo syndrome
Mr E. Zulfaj (Gothenburg, SE)
Abstract Slides Video
Presentation thumbnail
Elucidation of the mechanistic links connecting non-alcoholic fatty liver disease and heart failure with preserved ejection fraction in mice
Associate Professor R. Asleh (Jerusalem, IL) Mrs N. Rweished (Jerusalem, IL)
Abstract Slides

Access the full session

Session thumbnail
Basic science - cardiac disease 1

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
Effect of empagliflozin with or without sacubitril/valsartan on the lipoprotein, glycoprotein and lipid profile in a porcine model of myocardial infarction
thumbnail
Congress Presentation
Beneficial effects of treatment with a soluble guanylate cyclase stimulator on cardiac function and mitochondrial activity in an animal model of early-stage HFpEF
thumbnail
Congress Presentation
Effects of sacubitril-valsartan alone or in combination with dapagliflozin on aging-related heart failure with preserved ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources